Stories

OHSU Cancer Institute Appoints Craig Nichols, M.D., Associate Director Of Cancer Clinical Research

January 09, 2007

Oregon Health & Science University Cancer Institute is pleased to announce that Craig Nichols, M.D. will assume full-time duties as associate director for the institute's Cancer Clinical Research program. Nichols brings to the OHSU Cancer Institute ...

Pushing Environmental Biomedical Research Out to Sea

November 17, 2005

Imagine a marine animal that fights cancer. Or a microcsopic sea plant that counteracts the greenhouse effect. Or even marine bacteria that clean up Superfund pollution sites. These are all plausible scenarios for a pair of well-known marine ...

Pushing Environmental Biomedical Research Out to Sea

November 17, 2005

Imagine a marine animal that fights cancer. Or a microcsopic sea plant that counteracts the greenhouse effect. Or even marine bacteria that clean up Superfund pollution sites. These are all plausible scenarios for a pair of well-known marine ...

OHSU Studies New Drug For Ovarian Cancer Patients

November 08, 2005

A new targeted, "silver bullet" drug is being given to women with ovarian cancer to improve their survival as part of a new study by an Oregon Health & Science University researcher and surgical oncologist. The drug, Telcyta, has been shown in animal ...

OHSU Studies New Drug For Ovarian Cancer Patients

November 08, 2005

A new targeted, "silver bullet" drug is being given to women with ovarian cancer to improve their survival as part of a new study by an Oregon Health & Science University researcher and surgical oncologist. The drug, Telcyta, has been shown in animal ...

Vitamin D, Taxotere Combination Extends The Lives Of Men With Advanced Prostate Cancer

November 02, 2005

Men with advanced prostate cancer who take an experimental, high-dose vitamin D pill with chemotherapy live about eight months longer than those receiving chemotherapy and placebo, according to a new study. The pill is DN-101. Designed specifically as ...

Vitamin D, Taxotere Combination Extends The Lives Of Men With Advanced Prostate Cancer

November 02, 2005

Men with advanced prostate cancer who take an experimental, high-dose vitamin D pill with chemotherapy live about eight months longer than those receiving chemotherapy and placebo, according to a new study. The pill is DN-101. Designed specifically as ...

Study Suggests Common Cholesterol-Lowering Drugs Can Reduce Prostate Cancer Risk

November 01, 2005

Men who take even small amounts of common cholesterol-lowering drugs such as Lovastatin and Simvastatin reduce their risk of prostate cancer by 65 percent, according to a new Oregon Health & Science University Cancer Institute study published in a ...

Study Suggests Common Cholesterol-Lowering Drugs Can Reduce Prostate Cancer Risk

November 01, 2005

Men who take even small amounts of common cholesterol-lowering drugs such as Lovastatin and Simvastatin reduce their risk of prostate cancer by 65 percent, according to a new Oregon Health & Science University Cancer Institute study published in a ...

Dirty Drugs Have Their Day

October 25, 2005

Just how 'dirty' should a cancer drug be? While it's not a question cancer patients typically ponder, the answer could profoundly affect their treatment. Dirty drugs - those that simultaneously inhibit more than one of a tumor's driving forces - are ...

Stories

OHSU in the News